BioMarin Pharmaceutical Inc. buy Sanford C. Bernstein
Start price
20.08.24
/
50%
€85.64
Target price
20.08.25
€99.09
Performance (%)
-42.16%
End price
21.08.25
€49.53
Summary
This prediction ended on 21.08.25 with a price of €49.53. The BUY prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc. performed very badly with a performance of -42.16%. Sanford_C__Bernstein has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.129% | -0.129% | -10.727% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Sanford_C__Bernstein for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $110.00 price target on the stock, up previously from $94.00.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Sanford_C__Bernstein gewählte maximale Laufzeit wurde überschritten
Current prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.42
25.02.26
25.02.26
€79.75
25.02.27
25.02.27
-11.41%
17.04.26
17.04.26
Stopped prediction by Sanford_C__Bernstein for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€80.87
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25